Has Stephen Sharpe received payments from drug or device companies?

Yes. Drug and device makers reported $3,916 in general payments to Stephen Sharpe across 173 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stephen Sharpe did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stephen Sharpe come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stephen Sharpe

Physician Assistant · Nashville, TNNPI 1831277755

Payments from drug & device makers

$3,916in general payments, 2019–2025

Across 173 payments — averaging $22.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Gilead$961
AbbVie$740
Viiv Healthcare Company$642
Merck$323
Novo Nordisk$268
Lilly USA, LLC$180
plus $803 from 17 others

$195in research payments, 2019–2025

Across 1 payment — averaging $195.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$195

What the payments were for

Food & beverage$3,915100%
Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Gilead	32	$961
AbbVie	34	$740
Viiv Healthcare Company	27	$642
Merck	14	$323
Novo Nordisk	11	$268
Lilly USA, LLC	11	$180
Biohaven Pharmaceuticals, Inc.	7	$122
Boehringer Ingelheim	6	$118
Johnson & Johnson	5	$72
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	4	$71
Otsuka America Pharmaceutical, Inc.	2	$69
Pfizer	3	$55
AstraZeneca	4	$51
GSK	2	$37
Jazz Pharmaceuticals Inc.	2	$37
Amarin Pharma, Inc.	2	$33
Amgen	1	$25
Optos, Inc.	1	$22
Ultragenyx Pharmaceutical Inc.	1	$20
Esperion Therapeutics, Inc.	1	$19
Exact Sciences	1	$19
Axsome Therapeutics, Inc.	1	$17
Bausch Health US, LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,916 in reported general payments places this provider in the 85th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
TrulicityDulaglutide	12	$11,216
Albuterol Sulfate HfaAlbuterol Sulfate	16	$377
Buspirone Hcl	11	$342
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine	11	$341
Gabapentin	11	$306
Sumatriptan Succinate	11	$113
Amlodipine Besylate	12	$75
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide	11	$57
Alprazolam	22	$37
Losartan Potassium	13	$33
Metoprolol Tartrate	12	$25

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Lilly USA, LLCTrulicity	$180	$11,21612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Nashville

Jason HenryNashville$329K
Brie ChandlerNashville$317K
John KramerNashville$125K
Elisabeth BennettNashville$109K
Nicholas BarkemeyerNashville$85K
Rachel ConklinNashville$60K
Aaron MankinNashville$53K
Marci KleinrockNashville$39K
Kevin GriffinNashville$18K
Walter SimsNashville$18K

See the full list for Tennessee →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →